Panacea Biotec share news, announcements and annual reports
NSE: PANACEABIOBSE: 531349Pharmaceuticals & BiotechnologySmall Cap
Panacea Biotec Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1996 on BSE, Apr 1996 on NSE
Last close ₹313.25down ₹12.65 (3.88%)BSE ₹312.95
Share price at the NSE close on 30 Oct 2026. Previous close ₹325.90.
30 Oct: open ₹323.05, high ₹325.95, low ₹311.10
52-week range of traded prices to 30 Oct 2026
₹292.40Low, 30 Mar 2026₹647.00High, 9 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,919 Cr1,088th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.30
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −0.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹11 crore of one-off items, the largest of them in the quarter to Dec 2025.
- −2.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −3.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 57,86658.2% delivered
Panacea Biotec share news and announcements
875 announcements, routine notices left out, newest first. Page 14 of 18.
Oct 2014
20 Oct · Board meeting
To inter-alia, consider and approve the Unaudited Financial Results (Provisional) for the quarter and half-year ended September 30, 2014.
Sep 2014
29 Sep · Disclosure of Voting Pattern - Clause 35A
Aug 2014
5 Aug · Meeting
Company has fixed Book Closure from September 19, 2014 to September 25, 2014 (both days inclusive) for the purpose of Annual General Meeting of the Company scheduled to be held on September 25, 2014.1 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 01, 2014 has decided to raise funds by way of issue of equity share and/or other securities etc. aggregating upto Rs. 250 Crore or equivalent thereof in any currency, subject to approval of the Shareholders.
Jul 2014
23 Jul · Board meeting
To inter-alia, consider and approve the Unaudited Financial Results (Provisional) for the quarter ended June 30, 2014 and raising of funds by way of issue of securities aggregating upto Rs.250 Crore or equivalent thereof in any currency. The trading window of the Company shall remain closed for the promoters, directors, officers and designated employees of the Company from July 23, 2014 to August 02, 2014 (both days inclusive) in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 1992 read with the Company's Code of Conduct for Prevention of Insider Trading.
May 2014
31 May · Board meeting
Board of Directors of the Company at its meeting held on May 30, 2014 has considered the following items: (1) In view of non-availability of profits, no dividend has been recommended on the Equity Shares of the Company for the financial year ended March 31, 2014.31 May · Board meeting
Feb 2014
13 Feb · Results
Jan 2014
27 Jan · Updates
Trading window of the Company shall remain closed for the promoters, directors, officers and designated employees of the Company from January 25, 2014 to February 14, 2014 (both days inclusive) in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 1992 read with the Company's Code of Conduct for Prevention of Insider Trading.
Nov 2013
25 Nov · Meeting
25 Nov · Disclosure of Voting Pattern - Clause 35A
14 Nov · Results
Oct 2013
30 Oct · Board meeting
To inter-alia, consider and approve the Unaudited Financial Results (Provisional) for the quarter and half year ended September 30, 2013.
Sep 2013
27 Sep · Disclosure of Voting Pattern - Clause 35A
Aug 2013
Jul 2013
25 Jul · Board meeting
To interalia, consider and approve the Unaudited Financial Results (Provisional) for the quarter ended June 30, 2013.
Jun 2013
4 Jun · Board meeting
Vide letter dated May 30, 2013 that the Board of Directors of the Company at its meeting held on May 30, 2013, has not recommended any dividend on the Equity Shares of the Company for the financial year ended March 31, 2013 in view of non-availability of profits.
May 2013
10 May · Board meeting
To inter-alia, consider and approve the Audited Financial Results for the Financial Year 2012-13.
Mar 2013
Feb 2013
6 Feb · News Verification
News Verification : The media had reports that Panacea Biotec Limited and builder Bestech Group will jointly develop a township project in Gurgaon. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Panacea Biotec Limited has vide its letter inter-alia stated, "We would like to state that the Company's wholly owned subsidiary, Best On Health Ltd. (BOH) has signed a Term Sheet with Bestech expiring on 28th February, 2013. The definitive agreement has yet not been reached. We are evaluating all our options, models and partners. The final call is yet to be taken."
Jan 2013
2 Jan · Board meeting
To inter-alia, consider and approve the Unaudited Financial Results (Provisional) for the quarter and nine months ended December 31, 2012.
Dec 2012
Nov 2012
Oct 2012
16 Oct · Board meeting
To inter-alia, consider and approve the Unaudited Financial Results (Provisional) for the quarter and half year ended September 30, 2012.1 Oct · Disclosure of Voting Pattern - Clause 35A
Sep 2012
18 Sep · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 24, 2012 to September 29, 2012 (both days inclusive) for the purpose of 28th Annual General Meeting (AGM) of the Company to be held on September 29, 2012.